Tongzhi Wu

University of Adelaide

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (8)

Maryam Hajishafiee

AUSTRALIA

View details

Nicolai J. Wewer Albrechtsen

DENMARK

View details

Carolyn Deacon

Københavns Universitet

DENMARK

View details

Christopher Rayner

University of Adelaide

AUSTRALIA

View details

Christine Feinle-Bisset

University of Adelaide

AUSTRALIA

View details

Michael Horowitz

University of Adelaide

AUSTRALIA

View details

Karen Jones

University of South Australia

AUSTRALIA

View details

Weikun Huang

University of Adelaide

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tongzhi Wu

Research Interests

Explore related searches

Contact this professor

Articles (23)

Metformin slows intestinal glucose absorption in type 2 diabetes, irrespective of the timing of its administration

The Impact of Tea Consumption on Prediabetes Regression and Progression: A Prospective Cohort Study

Impact of the timing of metformin administration on the plasma lactate response to intraduodenal glucose infusion in type 2 diabetes

Bariatric arterial embolization slows gastric emptying and improves postprandial glycaemia in obese dogs with impaired glucose tolerance

Letter to the Editor From Xie et al: “The 13C Glucose Breath Test Accurately Identifies Insulin Resistance in People With Type 1 Diabetes”

Impairments of insulin and glucagon sensitivity in Chinese women with gestational diabetes mellitus

Randomised comparison of intravenous and subcutaneous routes of glucagon‐like peptide‐1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes

Getting the measure of the pressure: Optimal assessment of the effects of glucagon‐like peptide‐1 receptor agonists on blood pressure

Sex differences in the plasma glucagon responses to a high carbohydrate meal and a glucose drink in type 2 diabetes

Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study

Effects of a bitter substance, denatonium benzoate, on pancreatic hormone secretion

Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide

Host or the Hosted? Effects of Non-Nutritive Sweeteners on Intestinal and Microbial Mechanisms of Glycemic Control

Serum alanine transaminase is predictive of fasting and postprandial insulin and glucagon concentrations in type 2 diabetes

Disparities in the Glycemic and Incretin Responses to Intraduodenal Glucose Infusion Between Healthy Young Men and Women

Effect of gastric distension with concurrent small intestinal saline or glucose infusion on incretin hormone secretion in healthy individuals: A randomized, controlled, crossover study

Determinants of blood glucose concentrations following a high carbohydrate meal in type 2 diabetes: A multiple linear regression analysis

Prevalence of Gastrointestinal Symptoms in Chinese Community-Dwelling Adults with and without Diabetes

Cholecystectomy is associated with dysglycaemia: Cross‐sectional and prospective analyses

Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit

Serum bile acid response to oral glucose is attenuated in patients with early type 2 diabetes and correlates with 2‐hour plasma glucose in individuals without diabetes

Plasma GLP-1 Response to Oral and Intraduodenal Nutrients in Health and Type 2 Diabetes—Impact on Gastric Emptying

Comment on Rosenstock et al. Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial. Diabetes Care 2020;43:2509–2518

Collaborators (8)

Maryam Hajishafiee

Nicolai J. Wewer Albrechtsen

Carolyn Deacon

Christopher Rayner

Christine Feinle-Bisset

Michael Horowitz

Karen Jones

Weikun Huang

Make your next move.